Clinical trial
Evaluation of the Safety and Efficacy of Mefloquine as Intermittent Preventive Treatment of Malaria in Pregnancy
NCT00811421 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Efficacy of Mefloquine as Intermittent Preventive Treatment of Malaria in Pregnancy
- Lead sponsor
- Hospital Clinic of Barcelona
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- December 31, 2013
- Enrollment
- 5,820 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infections, malaria, pregnancy